Search

Displaying results 7281 - 7290 of 10000 in total
  1. Drug

    Mannomustine

    go.drugbank.com/drugs/DB20616
    Experimental

    The usage of the INN stem '-mustine' in the name indicates that Mannomustine is a antineoplastic, alkylating agent, (β-chloroethyl) amine derivative.

  2. Drug

    Duoperone

    go.drugbank.com/drugs/DB20621
    Experimental

    The usage of the INN stem '-perone' in the name indicates that Duoperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative.

  3. Drug

    Erocainide

    go.drugbank.com/drugs/DB20634
    Experimental

    The usage of the INN stem '-cain-' in the name indicates that Erocainide is a class I antiarrhythmic, procainamide and lidocaine derivative.

  4. Drug

    Amiperone

    go.drugbank.com/drugs/DB20685
    Experimental

    The usage of the INN stem '-perone' in the name indicates that Amiperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative.

  5. Drug

    Sofnobrutinib

    go.drugbank.com/drugs/DB21626
    Experimental

    The usage of the INN stem '-brutinib' in the name indicates that Sofnobrutinib is a agammaglobulinaemia tyrosine kinase (Bruton tyrosine kinase) inhibitor.

  6. Drug

    Lacutoclax

    go.drugbank.com/drugs/DB21657
    Investigational

    The usage of the INN stem '-toclax' in the name indicates that Lacutoclax is a B-cell lymphoma 2 (Bcl-2) inhibitor. Lacutoclax has a monoisotopic molecular weight of 922.36 Da.

  7. Drug

    Vilzemetkib

    go.drugbank.com/drugs/DB21704
    Experimental

    The usage of the INN stem '-metkib' in the name indicates that Vilzemetkib is a MET (mesenchymal epithelial transition factor) kinase inhibitor.

  8. Drug

    SR 140333

    go.drugbank.com/drugs/DB05790
    Experimental

    SR 140333 is tachykinin antagonist which has potential to treat diarrhoea due to food allergy or inflammatory bowel disease.

  9. Drug

    NS-398

    go.drugbank.com/drugs/DB14060
    Experimental

    It was developed as part of the mechanistic study of the cyclooxygenases.

  10. Drug

    BZL101

    go.drugbank.com/drugs/DB05051
    Investigational

    BZL101 is an oral drug designed for the treatment of advanced breast cancer with a novel mechanism of action. BZL101 targets diseased cells while leaving normal cells healthy and intact.